Search
for

    GlossaryAndrogen Receptor Antagonists

    block male hormones like testosterone from affecting tissues

    Androgen Receptor Antagonists, also known as antiandrogens, are medications that block the action of androgens, which are male sex hormones like testosterone. These drugs work by binding to androgen receptors, preventing androgens from exerting their effects on tissues, and are commonly used in the treatment of conditions like prostate cancer, androgenic alopecia (male-pattern baldness), and certain types of acne.

    Related Terms

    Learn

    5 / 16 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Shedding again after 6 months of great results.

      in Minoxidil  15 upvotes 1 year ago
      A user experienced shedding after 7 months on Fin/Min spray despite good results and no change in treatment. Other users noted similar experiences and mentioned that shedding periods can be normal.

      community Does CosmeRNA target the root cause of MPB?

      in Chat 2 years ago
      . CumsOnYourFeet69 has been discussing a new treatment called CosmeRNA which claims to target the root cause of male pattern baldness, and is considering using it in conjunction with Minoxidil instead of Finasteride due to possible side effects. Replies have highlighted that the efficacy of this treatment is still unknown, but it could be used as an effective maintenance option if successful.

      community Topical finasteride might be a lie

      in Research/Science 2 years ago
      The conversation discusses doubts about the effectiveness of topical finasteride for hair loss, suggesting that DHT could be produced elsewhere in the body and affect the scalp. It proposes that androgen receptor antagonists like spironolactone and clascoterone might be more effective as they could prevent this potential bypass mechanism.